...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Determination of posaconazole levels in toenails of adults with onychomycosis following oral treatment with four regimens of posaconazole for 12 or 24 weeks.
【24h】

Determination of posaconazole levels in toenails of adults with onychomycosis following oral treatment with four regimens of posaconazole for 12 or 24 weeks.

机译:口服四次泊沙康唑方案治疗12或24周后,测定成人灰指甲的脚趾甲中泊沙康唑的水平。

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmacokinetic data from a randomized, parallel-group, multicenter study are presented. Adults with toenail onychomycosis (n = 146) received posaconazole (100 mg, 200 mg, or 400 mg) once daily (QD) for 24 weeks or 400 mg QD for 12 weeks. The posaconazole concentration in the great toenail exhibited a dose-related increase starting at week 2 for 24 weeks and a mean toenail-to-plasma concentration ratio of approximately 3:1 at the end of treatment for the 400-mg 24-week dose.
机译:呈现了来自随机,平行组,多中心研究的药代动力学数据。患有趾甲甲癣(n = 146)的成人每天接受一次泊沙康唑(100 mg,200 mg或400 mg)一次(QD),持续24周,或接受400 mg QD,持续12周。从第2周开始的24周内,大趾甲中的泊沙康唑浓度显示出剂量相关的增加,并且在400毫克的24周剂量治疗结束时,趾甲与血浆的平均浓度之比约为3:1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号